Significant reduction in mortality with streptokinase given 7-24 hours after pain onset.
Príomhchruthaitheoirí: | Collins, R, Peto, R, Sleight, P |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
1988
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Effects of streptokinase in patients presenting within 6 hours of prolonged chest pain with ST segment depression.
de réir: Collins, R, et al.
Foilsithe / Cruthaithe: (1995) -
ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.
de réir: Collins, R, et al.
Foilsithe / Cruthaithe: (1993) -
ISIS-2 - A LARGE RANDOMIZED TRIAL OF INTRAVENOUS STREPTOKINASE AND ORAL ASPIRIN IN ACUTE MYOCARDIAL-INFARCTION
de réir: Collins, R, et al.
Foilsithe / Cruthaithe: (1989) -
Holter monitoring of ventricular arrhythmias in a randomised, controlled study of intravenous streptokinase in acute myocardial infarction.
de réir: Alexopoulos, D, et al.
Foilsithe / Cruthaithe: (1991) -
RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
de réir: Collins, R, et al.
Foilsithe / Cruthaithe: (1987)